Evidence map›Paper›PMID 42394942›Full record

ArticleClinical parkinsonism & related disorders2026

Successful use of continuous subcutaneous Foslevodopa/Foscarbidopa in Parkinson's disease with bipolar disorder without psychiatric destabilization.

Joanna Siuda, Justyna Gawryluk, Amelia Krupczak, Mateusz Toś

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Clinical parkinsonism & related disorders, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Joanna SiudaDepartment of Neurology, Faculty of Medical Sciences in Katowice, Medical University of Silesia, Katowice, Poland.
Justyna GawrylukDepartment of Neurology, Faculty of Medical Sciences in Katowice, Medical University of Silesia, Katowice, Poland.
Amelia KrupczakStudents' Scientific Association, Department of Neurology, Faculty of Medical Sciences in Katowice, Medical University of Silesia in Katowice, Poland.
Mateusz TośDepartment of Neurology, Faculty of Medical Sciences in Katowice, Medical University of Silesia, Katowice, Poland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We report a patient with advanced Parkinson's disease and treatment-resistant bipolar disorder in whom continuous subcutaneous foslevodopa/foscarbidopa infusion improved motor fluctuations without psychiatric destabilization despite prior dopaminergic sensitivity. This case suggests that LDp/CDp may be a therapeutic option even in patients with bipolar disorder.

Indexed as

Advanced Parkinson’s diseaseBipolar disorderDevice-aided therapyFoslevodopa/foscarbidopaMood stability

Identifiers

PMID42394942
PMCPMC13324501

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.